Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""clear cell"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 14384
Tytuł:
Pulmonary salivary gland tumor-hyalinizing clear cell carcinoma: a literature review.
Autorzy:
Wang X; Zhejiang Key Laboratory of Diagnosis & Treatment Technology On Thoracic Oncology (Lung and Esophagus), Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang, China.; Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang, China.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310018, Zhejiang, China.; Postgraduate Training Base Alliance of Wenzhou Medical University, Wenzhou, 325035, People's Republic of China.
Hu S; Zhejiang Key Laboratory of Diagnosis & Treatment Technology On Thoracic Oncology (Lung and Esophagus), Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang, China.; Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang, China.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310018, Zhejiang, China.; The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China.
Lu H; Zhejiang Key Laboratory of Diagnosis & Treatment Technology On Thoracic Oncology (Lung and Esophagus), Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang, China. .; Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang, China. .; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310018, Zhejiang, China. .; Postgraduate Training Base Alliance of Wenzhou Medical University, Wenzhou, 325035, People's Republic of China. .; The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China. .
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2024 Feb 22; Vol. 19 (1), pp. 37. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Salivary Gland Neoplasms*/diagnosis
Salivary Gland Neoplasms*/genetics
Salivary Gland Neoplasms*/pathology
Lung Neoplasms*/genetics
Carcinoma*
Adenocarcinoma, Clear Cell*/diagnosis
Adenocarcinoma, Clear Cell*/genetics
Adenocarcinoma, Clear Cell*/pathology
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The impact of lymphadenectomy on ovarian clear cell carcinoma: a systematic review and meta-analysis.
Autorzy:
Liu Y; Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, China.
Geng F; Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Zhang H; Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Xue J; Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Chu R; Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2024 Jan 29; Vol. 22 (1), pp. 37. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Adenocarcinoma, Clear Cell*/surgery
Adenocarcinoma, Clear Cell*/pathology
Ovarian Neoplasms*/pathology
Humans ; Female ; Lymph Node Excision/methods ; Carcinoma, Ovarian Epithelial/surgery ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clear Cell Adenocarcinoma of Urethra: Clinical and Pathologic Implications and Characterization of Molecular Aberrations.
Autorzy:
Song B; Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Lee SH; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
Park JH; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.; Department of Pathology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea.
Moon KC; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2024 Jan; Vol. 56 (1), pp. 280-293. Date of Electronic Publication: 2023 Sep 11.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma, Clear Cell*/genetics
Adenocarcinoma, Clear Cell*/pathology
Humans ; Female ; Middle Aged ; Male ; Kelch-Like ECH-Associated Protein 1/genetics ; Urethra/pathology ; Phosphatidylinositol 3-Kinases ; Retrospective Studies ; NF-E2-Related Factor 2/genetics ; Mutation ; DNA Helicases/genetics ; Nuclear Proteins/genetics ; Transcription Factors/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Correlation of clinicopathological and prognostic characteristics between endometriosis-associated and primary ovarian cancer.
Autorzy:
Wang H; Department of Gynecology, Liaoning Cancer Hospital & Institute, 44 Xiaoheyan Road, Dadong District, Shenyang, Liaoning, 110004, China.
Chen C; Department of Gynecology, Liaoning Cancer Hospital & Institute, 44 Xiaoheyan Road, Dadong District, Shenyang, Liaoning, 110004, China.
Wang D; Department of Gynecology, Liaoning Cancer Hospital & Institute, 44 Xiaoheyan Road, Dadong District, Shenyang, Liaoning, 110004, China. .
Zhu Y; Department of Pathology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China. .
Chen P; Department of Gynecology, Liaoning Cancer Hospital & Institute, 44 Xiaoheyan Road, Dadong District, Shenyang, Liaoning, 110004, China.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Dec 08; Vol. 23 (1), pp. 1210. Date of Electronic Publication: 2023 Dec 08.
Typ publikacji:
Journal Article
MeSH Terms:
Endometriosis*/complications
Endometriosis*/diagnosis
Ovarian Neoplasms*/metabolism
Adenocarcinoma, Clear Cell*/pathology
Humans ; Female ; Prognosis ; Retrospective Studies ; Neoplasm Recurrence, Local/complications
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ureteral Metastasis of Colonic Adenocarcinoma with Enteroblastic Differentiation: A Rare Case to be Distinguished from Clear Cell Adenocarcinoma of the Urinary Tract.
Autorzy:
Minato H; Department of Diagnostic Pathology, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.
Yoshikawa A; Department of Diagnostic Pathology, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.
Tsuyama S; Department of Diagnostic Pathology, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.
Katayanagi K; Department of Diagnostic Pathology, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.
Hayashi K; Department of Gastroenterological Surgery, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.
Sakimura Y; Department of Gastroenterological Surgery, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.
Bando H; Department of Gastroenterological Surgery, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.
Hori T; Department of Urology, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.
Kito Y; Department of Medical Oncology, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2023 Dec; Vol. 31 (8), pp. 1553-1558. Date of Electronic Publication: 2023 Mar 09.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Adenocarcinoma, Clear Cell*/diagnosis
Carcinoma, Transitional Cell*
Stomach Neoplasms*/pathology
Urinary Bladder Neoplasms*
Colonic Neoplasms*/diagnosis
Colorectal Neoplasms*
Urinary Tract*/pathology
Female ; Humans ; Adult ; Biomarkers, Tumor ; Cell Differentiation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical, Histopathological and Immunohistochemical Aspects of Digital Papillary Adenocarcinoma: A Case Report and Literature Review.
Autorzy:
Yagci S; Department of Pathology, Başkent University Faculty of Medicine, ANKARA, TURKEY.
Terzi A; Department of Pathology, Başkent University Faculty of Medicine, ANKARA, TURKEY.
Albayati A; Department of Plastic and Reconstructive Surgery, Başkent University Faculty of Medicine, ANKARA, TURKEY.
Uysal AC; Department of Plastic and Reconstructive Surgery, Başkent University Faculty of Medicine, ANKARA, TURKEY.
Pokaż więcej
Transliterated Title:
Clinical, Histopathological and Immunohistochemical Aspects of Digital Papillary Adenocarcinoma: A Case Report and Literature Review.
Źródło:
Turk patoloji dergisi [Turk Patoloji Derg] 2024; Vol. 40 (1), pp. 69-73.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Adenocarcinoma, Papillary*/surgery
Adenocarcinoma, Papillary*/pathology
Carcinoma*
Adenocarcinoma, Clear Cell*
Female ; Humans ; Middle Aged ; Margins of Excision ; Epithelial Cells/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Primary Pulmonary Hyalinizing Clear Cell Carcinoma: Case Series With Review of Literature.
Autorzy:
Thakur S; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Nambirajan A; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Larsen BT; Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA.
Butt YM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA.
Roden AC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Kumar S; Department of Surgical Oncology, B.R.A., IRCH, All India Institute of Medical Sciences, New Delhi, India.
Jain D; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2023 Oct; Vol. 31 (7), pp. 1187-1194. Date of Electronic Publication: 2022 Dec 13.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Salivary Gland Neoplasms*/pathology
Adenocarcinoma, Clear Cell*/diagnosis
Adenocarcinoma, Clear Cell*/genetics
Adenocarcinoma, Clear Cell*/surgery
Humans ; Female ; Adult ; Middle Aged ; Male ; Retrospective Studies ; Biomarkers, Tumor/analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Conventional Chondrosarcoma with Clear Cell Features in the Rib: Report of Two Cases and Review of the Literature.
Autorzy:
Wangsiricharoen S; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Jalloh H; Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
James AW; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
McCarthy EF; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Morris CD; Department of Orthopedic Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Gross JM; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2023 Aug; Vol. 31 (5), pp. 621-626. Date of Electronic Publication: 2022 Jul 27.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Chondrosarcoma, Clear Cell*
Chondrosarcoma*/diagnosis
Chondrosarcoma*/surgery
Chondrosarcoma*/pathology
Bone Neoplasms*/diagnosis
Bone Neoplasms*/surgery
Bone Neoplasms*/pathology
Humans ; Cell Nucleus/pathology ; Ribs/surgery ; Ribs/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Primary pulmonary hyalinizing clear cell carcinoma with vocal-cord squamous cell carcinoma: a case report with systematic review.
Autorzy:
Li Z; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17, Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Li W; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17, Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Xue L; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17, Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China. .; Center for Cancer Precision Medicine, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. .
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2023 Aug 08; Vol. 18 (1), pp. 90. Date of Electronic Publication: 2023 Aug 08.
Typ publikacji:
Case Reports; Journal Article; Systematic Review
MeSH Terms:
Adenocarcinoma, Clear Cell*/genetics
Carcinoma, Squamous Cell*/genetics
Head and Neck Neoplasms*
Laryngeal Neoplasms*
Lung Neoplasms*/genetics
Salivary Gland Neoplasms*/pathology
Humans ; Neoplasm Recurrence, Local
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clear cell sarcoma of kidney: A mimicker of Wilms' tumor.
Autorzy:
Aviral G; Department of Pathology, Sanjay Gandhi Post-Graduate Institute Of Medical Sciences, Lucknow, Uttar Pradesh, India.
Sarvesh CM; Department of Radiodiagnosis, Sanjay Gandhi Post-Graduate Institute Of Medical Sciences, Lucknow, Uttar Pradesh, India.
Sushila J; Department of Pathology, Sanjay Gandhi Post-Graduate Institute Of Medical Sciences, Lucknow, Uttar Pradesh, India.
Ansari MS; Department of Urology, Sanjay Gandhi Post-Graduate Institute Of Medical Sciences, Lucknow, Uttar Pradesh, India.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Jul-Sep; Vol. 19 (5), pp. 1468-1470.
Typ publikacji:
Case Reports
MeSH Terms:
Sarcoma, Clear Cell*/diagnosis
Sarcoma, Clear Cell*/surgery
Sarcoma, Clear Cell*/pathology
Wilms Tumor*/diagnosis
Wilms Tumor*/surgery
Wilms Tumor*/pathology
Kidney Neoplasms*/diagnosis
Kidney Neoplasms*/surgery
Kidney Neoplasms*/pathology
Humans ; Child, Preschool ; Kidney/diagnostic imaging ; Kidney/pathology ; Biopsy
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Impact of the number of cycles of platinum-based chemotherapy for early stage ovarian clear cell carcinoma on survival: a retrospective study.
Autorzy:
Gao Y; Department of Gynecological Oncology, Tianjin Central Hospital of Gynecology Obstetrics Affiliated to Nankai University, No. 156 Nankai San Ma Road, Tianjin, 300100, China. .; Clinical College of Central of Gynecology and Obstetrics, Tianjin Medical University, Tianjin, China. .
Pokaż więcej
Źródło:
BMC women's health [BMC Womens Health] 2023 May 15; Vol. 23 (1), pp. 262. Date of Electronic Publication: 2023 May 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Ovarian Neoplasms*/pathology
Adenocarcinoma, Clear Cell*/drug therapy
Adenocarcinoma, Clear Cell*/pathology
Female ; Humans ; Retrospective Studies ; Platinum/therapeutic use ; Neoplasm Staging ; Disease-Free Survival ; Carcinoma, Ovarian Epithelial/drug therapy ; Chemotherapy, Adjuvant
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lymphocyte-activation gene 3 protein expression in tumor-infiltrating lymphocytes is associated with a poor prognosis of ovarian clear cell carcinoma.
Autorzy:
Zaitsu S; Departments of Obstetrics and Gynecology, Oita University Faculty of Medicine, Idaigaoka 1-1, Hasama-machi, Yufu-shi, Oita, 879-5593, Japan.
Yano M; Departments of Obstetrics and Gynecology, Oita University Faculty of Medicine, Idaigaoka 1-1, Hasama-machi, Yufu-shi, Oita, 879-5593, Japan. .; Department of Pathology, Saitama Medical University International Medical Centre, Saitama, Japan. .
Adachi S; Departments of Obstetrics and Gynecology, Oita University Faculty of Medicine, Idaigaoka 1-1, Hasama-machi, Yufu-shi, Oita, 879-5593, Japan.
Miwa M; Department of Gynecologic Oncology, Saitama Medical University International Medical Centre, Saitama, Japan.
Katoh T; Department of Pathology, Saitama Medical University International Medical Centre, Saitama, Japan.
Kawano Y; Departments of Obstetrics and Gynecology, Oita University Faculty of Medicine, Idaigaoka 1-1, Hasama-machi, Yufu-shi, Oita, 879-5593, Japan.
Yasuda M; Department of Pathology, Saitama Medical University International Medical Centre, Saitama, Japan.
Pokaż więcej
Źródło:
Journal of ovarian research [J Ovarian Res] 2023 May 13; Vol. 16 (1), pp. 93. Date of Electronic Publication: 2023 May 13.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma, Clear Cell*/genetics
Adenocarcinoma, Clear Cell*/pathology
Ovarian Neoplasms*/pathology
Female ; Humans ; Lymphocytes, Tumor-Infiltrating/metabolism ; Neoplasm, Residual/metabolism ; Neoplasm, Residual/pathology ; Carcinoma, Ovarian Epithelial/pathology ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genomic landscapes of ovarian clear cell carcinoma from latin countries reveal aberrations linked to survival and progression.
Autorzy:
Batista MP; Department of Internal Medicine, Medical School of Ribeirão Preto and Center for Cell Based Therapy, University of São Paulo, 14051-140, Tenente Catao Roxo, 2501, Ribeirão Preto, Brazil. .
Roffé M; Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
Romero I; Gynecological Oncology Area, Valencian Institute of Oncology Foundation, Valencia, Spain.
López-Guerrero JA; Gynecological Oncology Area, Valencian Institute of Oncology Foundation, Valencia, Spain.
Illueca C; Gynecological Oncology Area, Valencian Institute of Oncology Foundation, Valencia, Spain.
Lopez R; Gynecological Oncology Area, Valencian Institute of Oncology Foundation, Valencia, Spain.
Balieiro Anastácio da Costa AA; Department of Gynecologic Oncology, A.C.Camargo Cancer Center, São Paulo, Brazil.
De Brot L; Department of Pathology, A.C.Camargo Cancer Center, São Paulo, Brazil.
Molina JP; Medical Oncology Service, México Hospital, CCSS, San José, Costa Rica.
Barboza L; Pathological Anatomy Service, San Juan de Dios Hospital, San José, Costa Rica.
Peria FM; Department of Internal Medicine, Medical School of Ribeirão Preto and Center for Cell Based Therapy, University of São Paulo, 14051-140, Tenente Catao Roxo, 2501, Ribeirão Preto, Brazil.
Chaud F; Department of Internal Medicine, Medical School of Ribeirão Preto and Center for Cell Based Therapy, University of São Paulo, 14051-140, Tenente Catao Roxo, 2501, Ribeirão Preto, Brazil.
Gouvêa Yamada AS; Department of Internal Medicine, Medical School of Ribeirão Preto and Center for Cell Based Therapy, University of São Paulo, 14051-140, Tenente Catao Roxo, 2501, Ribeirão Preto, Brazil.
Poveda A; Oncogynecologic Department, Quironsalud Hospital, Valencia, Spain.
Rego EM; Department of Internal Medicine, Medical School of Ribeirão Preto and Center for Cell Based Therapy, University of São Paulo, 14051-140, Tenente Catao Roxo, 2501, Ribeirão Preto, Brazil.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Jul 03; Vol. 23 (1), pp. 613. Date of Electronic Publication: 2023 Jul 03.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/pathology
Carcinoma*
Adenocarcinoma, Clear Cell*/pathology
Female ; Humans ; Genomics ; Brazil
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma.
Autorzy:
Liu X; Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Shanghai Key Laboratory of Gynecologic Oncology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Department of Gynecological Oncology, the Affiliated Cancer Hospital, School of Medicine, University of Electronic Science and Technology of China, Sichuan Cancer Hospital & Institute, Chengdu, China.
Lu H; Department of Gynecologic Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Zhou Y; Department of Obstetrics and Gynecology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China.
Long X; Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Shanghai Key Laboratory of Gynecologic Oncology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Li Q; Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Shanghai Key Laboratory of Gynecologic Oncology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhuang G; State Key Laboratory of Oncogene and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yin X; Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Shanghai Key Laboratory of Gynecologic Oncology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Di W; Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Shanghai Key Laboratory of Gynecologic Oncology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 May; Vol. 12 (10), pp. 11385-11395. Date of Electronic Publication: 2023 Mar 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Nomograms*
Adenocarcinoma, Clear Cell*/therapy
Female ; Humans ; Neoplasm Staging ; Ascites ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Cases of Yolk sac tumor associated with gynecological malignant tumor.
Autorzy:
Wang S; Department of Gynecological Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, Zhejiang, China.
Chen K; Department of Gynecological Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, Zhejiang, China.
Chen Q; Department of Gynecological Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, Zhejiang, China.
Huang S; Department of Gynecological Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, Zhejiang, China.
Lu W; Department of Gynecological Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, Zhejiang, China. .
Pokaż więcej
Źródło:
BMC women's health [BMC Womens Health] 2023 Jun 30; Vol. 23 (1), pp. 348. Date of Electronic Publication: 2023 Jun 30.
Typ publikacji:
Case Reports
MeSH Terms:
Adenocarcinoma, Clear Cell*
Carcinoma, Endometrioid*/complications
Endodermal Sinus Tumor*/complications
Genital Neoplasms, Female*
Ovarian Neoplasms*/complications
Female ; Humans
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Analysis of survival and prognostic factors of clear cell adenocarcinoma of the prostate: a case-control study for a rare cancer entity.
Autorzy:
Chen S; Department of Urology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410005, Hunan Province, China.
Song W; Department of Urology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410005, Hunan Province, China.
Zhang R; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.; Department of Urology, Fujian Provincial Hospital, Fuzhou, China.
Jin Y; Department of Urology, Juntendo University School of Medicine, Tokyo, Japan.
Lu Y; Department of Urology, Juntendo University School of Medicine, Tokyo, Japan.
Lin L; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.; Department of Urology, Fujian Provincial Hospital, Fuzhou, China.
Ye L; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.; Department of Urology, Fujian Provincial Hospital, Fuzhou, China.
Li T; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China. .; Department of Urology, Fujian Provincial Hospital, Fuzhou, China. .
Wei Y; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China. .; Department of Urology, Fujian Provincial Hospital, Fuzhou, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jun 26; Vol. 13 (1), pp. 10317. Date of Electronic Publication: 2023 Jun 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma, Clear Cell*
Carcinoma, Acinar Cell*
Prostatic Neoplasms*/pathology
Male ; Humans ; Aged ; Case-Control Studies ; Prostate/pathology ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations.
Autorzy:
Stružinská I; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. .; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, Prague 2, 12800, Czech Republic. .
Hájková N; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Hojný J; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Krkavcová E; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Michálková R; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Dvořák J; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Němejcová K; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Matěj R; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; Department of Pathology, Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, Prague, 3rd, Czech Republic.; Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University, Thomayer University Hospital, Prague, Czech Republic.
Laco J; The Fingerland Department of Pathology, Faculty of Medicine in Hradec Kralove, Charles University, University Hospital Hradec Kralove, Prague, Czech Republic.
Drozenová J; Department of Pathology, Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, Prague, 3rd, Czech Republic.
Fabian P; Department of Oncological Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Hausnerová J; Department of Pathology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic.
Méhes G; Department of Pathology, Faculty of Medicine, University of Debrecen, Debrecen, 4032, Hungary.
Škapa P; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Švajdler M; Šikl's Department of Pathology, The Faculty of Medicine, Faculty Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
Cibula D; Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
Frühauf F; Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
Bártů MK; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Dundr P; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. .; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, Prague 2, 12800, Czech Republic. .
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2023 Jun 12; Vol. 18 (1), pp. 72. Date of Electronic Publication: 2023 Jun 12.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*
Adenocarcinoma, Clear Cell*/genetics
Humans ; Gene Expression Profiling ; Gene Fusion ; Genomics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A nomogram for predicting cancer-specific survival in patients with uterine clear cell carcinoma: a population-based study.
Autorzy:
Cheng WL; Department of Outpatient, West China Second University Hospital, Sichuan University, Chengdu, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
Wang RM; Department of Outpatient, West China Second University Hospital, Sichuan University, Chengdu, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhao Y; Department of Outpatient, West China Second University Hospital, Sichuan University, Chengdu, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
Chen J; Department of Outpatient, West China Second University Hospital, Sichuan University, Chengdu, China. .; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jun 07; Vol. 13 (1), pp. 9231. Date of Electronic Publication: 2023 Jun 07.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Endometrial Neoplasms*
Adenocarcinoma, Clear Cell*
Humans ; Female ; Nomograms ; Uterus ; Research ; SEER Program ; Prognosis ; Neoplasm Staging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR.
Autorzy:
Chien W; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA. .
Tyner JW; Knight Cancer Institute, Oregon Health & Science University, Oregon Health and Science University, 2720 S.W. Moody Avenue, Portland, OR, 97201, USA.
Gery S; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA.
Zheng Y; Clinical Big Data Research Center, Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, 518107, P. R. China.
Li LY; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Shantou University Medical College, Shantou, Guandong Province, P. R. China.
Gopinatha Pillai MS; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA.
Nam C; Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA, 90089, USA.
Bhowmick NA; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA.
Lin DC; Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA, 90089, USA.
Koeffler HP; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA.; Department of Hematology-Oncology, National University Cancer Institute of Singapore, National University Hospital, Singapore, 119074, Singapore.
Pokaż więcej
Źródło:
Journal of ovarian research [J Ovarian Res] 2023 Apr 22; Vol. 16 (1), pp. 80. Date of Electronic Publication: 2023 Apr 22.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma, Clear Cell*/drug therapy
Adenocarcinoma, Clear Cell*/pathology
Ataxia Telangiectasia Mutated Proteins*/antagonists & inhibitors
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/pathology
Protein-Tyrosine Kinases*/antagonists & inhibitors
Female ; Humans ; Carcinoma, Ovarian Epithelial ; Cell Cycle Proteins/metabolism ; China ; TOR Serine-Threonine Kinases/metabolism ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Survival outcomes and the prognostic significance of clinicopathological features in patients with endometrial clear cell carcinoma: a 35-year single-center retrospective study.
Autorzy:
Ma X; National Clinical Research Center for Obstetric & Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
Cao D; National Clinical Research Center for Obstetric & Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China. .
Zhou H; National Clinical Research Center for Obstetric & Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
Wang T; National Clinical Research Center for Obstetric & Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
Wang J; National Clinical Research Center for Obstetric & Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
Zhang Y; National Clinical Research Center for Obstetric & Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
Yu M; National Clinical Research Center for Obstetric & Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
Cheng N; National Clinical Research Center for Obstetric & Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
Peng P; National Clinical Research Center for Obstetric & Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
Yang J; National Clinical Research Center for Obstetric & Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
Huang H; National Clinical Research Center for Obstetric & Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
Shen K; National Clinical Research Center for Obstetric & Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2023 Mar 27; Vol. 21 (1), pp. 106. Date of Electronic Publication: 2023 Mar 27.
Typ publikacji:
Journal Article
MeSH Terms:
Uterine Neoplasms*/pathology
Endometrial Neoplasms*/surgery
Adenocarcinoma, Clear Cell*/surgery
Adenocarcinoma, Clear Cell*/pathology
Carcinoma*/pathology
Carcinoma, Endometrioid*/pathology
Humans ; Female ; Aged ; Middle Aged ; Prognosis ; Retrospective Studies ; Neoplasm Staging ; Neoplasm Recurrence, Local/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 14384

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies